Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare IBRUTINIB (Imbruvica) and LORLATINIB (Lorbrena) — clinical data, side effects, and patient experiences.
Imbruvica · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Ibrutinib is a small-molecule inhibitor of Bruton’s tyrosine kinase (BTK). Ibrutinib forms a covalent bond with a cysteine residue in the BTK active site, ...
Approved for
Lorbrena · Targeted Cancer Therapy
How it works
12.1 Mechanism of Action Lorlatinib is a kinase inhibitor with in vitro activity against ALK and ROS1 as well as TYK1, FER, FPS, TRKA, TRKB, TRKC, FAK, FAK2, and ACK. Lorlatinib de...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 16 Reddit discussions
IBRUTINIB
56%
positive
9 threads
LORLATINIB
43%
positive
7 threads
% of discussions mentioning each side effect
9 Reddit threads analysed for IBRUTINIB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
48 upvotes
Most discussed side effects in community
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hey everyone, get ready for some deep due diligence, this time not for REGAL, but for SLS-009, buyout, and what the future will look like with buyout from a strategic acquirer. Before I start, I would suggest for those haven’t yet, read Part 1 and Part 2 that goes over the deep due diligence and mac
Hi everyone. I’m looking for insight from others with CLL experience. My dad has CLL with 96% involvement in his bone marrow per recent biopsy. His platelets are low, and over the past two weeks his anemia has worsened very very quickly. Recent timeline: Hospitalized with hemoglobin \~7.5 and fever
To Those Who Wish to learn, I feel like I may be giving away a secret.... but... here it goes... Earlier today I had a [twitter conversation](https://twitter.com/sentivcapital/status/1663230898702106634) about AI in regards to potential for future impact on stocks. I received a lot of DMs and to be
I’ve been pretty successful in a media career but now, at 43, 3 years post my diagnosis with my cancer under control (no cure... a rare lymphoma/on ibrutinib forever) two kids 7 and 4 at home and the sole breadwinner for the family, I’m so disenchanted. I finally feel great health wise... back to m
I was researching to find out * Examples of cancer drugs in the past that came to market later where treatments already existed, but ended up being commercially successful - * What were the characteristics of these late entrants that led to their success and does Cosibelimab have some of these char
**Is progression a meaningful outcome measure for a patient with indolent lymphoma** **If I don't feel anything (i.e. asymptomatic) and can live for decades with my lymphoma should I even worry about the fact that I have some enlarged lymph nodes or abnormalities of my lab work ???** I had a dis
Apparently a patient had been administering the medication this way... It's on the ISMP do not crush list. I called the manufacturer (Pharmacyclics) and they had no data on administering through any enteral feeding tubes, so they recommended not to give the medication in this manner. I can't find an
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
7 Reddit threads analysed for LORLATINIB
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
13 upvotes
Hey everyone, Long story short: I’m 27 and was recently diagnosed with stage 4 lung cancer ALK positive. It’s not curable, so I’ll be living with this for the rest of my life. I’m currently being treated at Memorial Sloan Kettering, and I’ll need to stay on a very specific (and very expensive) targe
HEADS UP THIS IS A LONG ONE!!! The past two years I’ve (27F) been dealing with severe breathing / wheezing problems. My PCP thought it was asthma, I was handed a pump and some montelukast. It continued and continued but I got used to it at a certain point and believed my doctor that it was just asth
Hello everyone, I’m writing as both a pulmonologist and a son. My mother has ALK-positive lung cancer, diagnosed in 2021. She has been on lorlatinib (Lorviqua) since March 2023, currently 50 mg daily, with an excellent and durable response, including complete response on recent scans. We are unfortu
I am a care partner for a 32 yr old Male who was just diagnosed with stage 4 NSCLC. Mets to liver, brain, bones (hip/spine) and lymph nodes. He got his ALK + diagnosis today and it was the first piece of ‘good news’ in weeks. His doctor has given him the option or Lorlatinib or a clinical study wher
A renowned oncologist specializing in targeted therapy and genetic treatment is now advising us to start **Lorlatinib** instead of **Lynparza** to treat my mom's (64F) pancreatic cancer with liver mets. Opposing what our current oncologist has advised us to do after we stopped chemo due to high bili
My dad has (60M) Stage IV NSCLC ALK+. Currently on Lorlatinib. It was effective for a bit but recent scans showed that the metastasized spots grew. Now, what are the alternative/ possible treatments to get it back under control? If anyone has any experience or thoughts, I would be very interested t
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both IBRUTINIB and LORLATINIB belong to the Targeted Cancer Therapy class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.
IBRUTINIB carries 4 FDA warnings. LORLATINIB carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.